Claim:
Recently, we have found out that some people in China are using the name of BIT to set-up false conference sites, in order for our participants to identify BIT's conferences, please click here for our forthcoming confereces! BIT will not take any responsibilities for conferences which are not listed.
BIT's 7th International Drug Discovery Science and Technology (IDDST), held in Shanghai Everbright Convention and Exhibition Center on October 22-25, achieved a consummation. The theme of this conference is "Milestones of Innovative Therapeutics". Over 400 honored guests presented at the ceremony and gave brilliant speeches on invitation, among them are Mr. Liu Hailin, Deputy Director-General of China Medicinal Biotech Association; Mr. Weimao Huang, Deputy Director of Shanghai Municipal Bureau of Foreign Experts; Dr. Xiaodan Mei, the Executive Chair of IDDST-2009, President of BIT Life Sciences; Dr. Aaron Ciechanover, Nobel Prize Laureate in Chemistry, 2004, Professor, Vascular and Cancer Biology Research Center, The Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Israel; Dr. Andreas Claudius Tschirky, the General Manager of Roche R&D Center China (RRDCC); Dr. Jing-Shan Hu, Director of Licensing & External Research (Mainland China, Hong Kong, & Taiwan), Merck & Co., USA; Dr. Chris Senanayake, Vice President, Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., USA; Derek Ren ( VP, Disocvery Biology,, Viva Biotech Ltd); Dr.Thierry Coche, Director Late Clinical Development Immunotherapeutics Business Unit, GlaxoSmithKline Biologicals S.A., Belgium; Dr.Christine Munz , Regional Marketing Manager, Asia Pacific. More than 600 world-renowned experts, professors, laboratory principals, project leaders and representatives of well-known enterprises attended the conference.
This annual congress comprised 8 Tracks and 61 sessions following the ceremony, including “Satellite Symposium: Emerging Approaches to Improve Medicine, sponsored by Roche Applied Science”; “Basic Sciences of Preclinical Studies”; “Methodology & Innovative tools for drug discovery, Drug delivery and Drug Development”; “Drug Discovery of Major Diseases”…etc. Meanwhile, A huge success has been achieved by BIT science in hosting IDDST annual congress in shanghai which also supported by OMICS, Roche, Merck & Co. Ltd. PerkinElmer Instruments, and Viva Biotech Ltd.
This annual conference, brought together nearly 600 specialists from 30 countries and areas, was devoted to the leading issues and popular topics and provide up-to-date information to all over the world. On the other hand, the meeting provided a brilliant information platform for domestic researchers to communicate with international experts and pushed forward the drug discovery development.
According to the investigation after the conference, most of our participants expressed that they would like to attend IDDST in the next year. Depending on the warmly support and good suggestions from all of the participants, we are quite confident in organizing IDDST-2010 which would be better and more successful than IDDST-2009. All of us are looking forward to meeting you again in 2010.
Prof. Aaron Ciechanover, Nobel Prize Laureate in Chemistry, 2004;
Institute of Technology, Isreal
Dr. Vincent G. Brichard, Vice President, Head of Immunotherapeutics Business Unit, GlaxoSmithKline Biologicals, Belgium
Dr. Chris Senanayake, Vice President,
Chemical Development,
Boehringer
Ingelheim Pharmaceuticals,
Inc., USA
Dr. Andreas Tschirky,
Roche's head of R&D in China
Reserved for VP of Merck & Co, Inc, USA
Dr. Alex Kiselyov , President, deCODE chemistry, USA
Dr. Thaddeus Grasela, President & CEO, Cognigen Corporation, USA
Dr. Miodrag Micic , Vice President, Research & Development, MP Biomedicals, LLC, USA
Dr. Michael F.G. Schmidt, Professor and Chairman, Dept. Immunology and Molecular Biology, Berlin Veterinary Faculty, Freie Universität Berlin, German y
Dr. M. Michael Swindle,
Professor &
Chairman Comparative Medicine, Medical University of South Carolina, USA
Dr. Karl-Anton Kreuzer, Professor, Department I of Internal Medicine, University at Cologne, Germany
Dr. King Lee, VP Regulatory/Clinical Affairs, Cornerstone Pharmaceuticals, USA
Dr. George Lin , Chief Medical Officer, Biological Mimetics, Inc., USA
Dr. Steven Bodovitz,
Principal, BioPerspectives,
USA
Dr. Mirko Diksic , Professor & Director, McGill University, Canada
Dr. Dominic M. Desiderio, Professor, University of Tennessee Health Science Center, USA
Dr. Andrew K. Godwin , Director, Clinical Molecular Genetics Laboratory, Fox Chase Cancer
Center, USA
Dr. Peter Ghosh , CEO, ProteoBioactives Pty Ltd., Australia
Mr. Anthony Johnson, President/CEO,
Empire Genomics,
USA
Dr. Tomi Sawyer , CSO, Aileron Therapeutics, USA
Dr. Sohaib Khan, Professor & Vice Chair, UC College of Medicine, USA
Dr. Johan Weigelt, Associate Director/Chief Scientist, Structural Genomics Consortium, Karolinska Institutet, Sweden
Dr. Matthias von Herrath,
Professor, University of California, San Francisco, USA
Dr. Jutta Bachmann, Principal and Founder, Bachmann Consulting, Norway
Dr. Dmitry Samarsky, Vice President, Technology Development, RXi Pharmaceuticals, USA
Dr. Ekambar Kandimalla, Vice President, Discovery, Idera Pharmaceuticals, USA
Dr. Leonard B. Saltz, Professor, Gastrointestinal Oncology Service, Memorial Sloan-Kettering Cancer Center, USA
Dr. Mark S. Kindy , Professor, Director of Neurosciences Institute, Medical University of South Carolina, USA
Dr. Mitchell Ho,
Head, Antibody Therapy Unit, National Cancer Institute, NIH, USA
Dr. John H. Van Drie, President, John H Van Drie Research LLC, USA
Dr. Manni Kantipudi , President, GVK Biosciences Private Limited, India
Dr. CSN Murthy, CEO, Aurigene Discovery Technologies Ltd, India
Dr. Edward O'Brien, Professor & Research Chair, University of Ottawa Heart Institute, Canada
Dr. Ronald J Quinn, Professor & Director, Eskitis Institute for Cell and Molecular Therapies, Griffith University, Australia
Dr. Hans-Joachim Knolker, Professor, Department at the Technical University of Dresden ,Germany
Dr. Nikolay Savchuk, CEO, Chemdiv, Russia
Dr. Goutam Das, COO, Syngene Intl Ltd, India
Dr. Swapan Bhattacharya, Managing Director, TCG Lifesciences, India
Dr. David Craik , Professor, Institute for Molecular Bioscience, The University of Queensland, Australia
Dr. Michael E. Johnson , Professor and Director, Center for Pharmaceutical Biotechnology, University of Illinois at Chicago, USA
Dr. Ingo Ott, Professor, Institute of Pharmaceutical Chemistry, Technical University Braunschweig, Germany
Dr. Lihu Yang , Director, Merck Research Laboratories, Merck & Co., USA
Dr. Jurgen Wagner, Director, Transplantation Research, Novartis Pharma AG, Switzerland
Dr. Ming Wang , Scientific Director, Amgen, Inc., USA
Dr. Eckard Hamelmann , Professor of Pediatrics and Allergy,Ruhr University, Germany
Dr. Oscar Joseph Trask, Head, Cellular Imaging Technologies, Duke University, USA
Dr. Tim Hammonds ,
Head , Biochemistry and HTS, Cancer Research Technology, UK
Dr. Jun Shi , Senior Director, Daiichi Sankyo Pharma Development, Japan
Dr. Steven Hayes, Director, BellBrook Labs, LLC, USA
In 2009, this is an exciting time for those in drug discovery and development field once again. With the emphasis on the practical, actionable ideas for accelerating discovery and early development, the 7th congress will be the great opportunity for the world’s leading scientists and executives to share with you the latest advancements in viral studies and their strategic approaches to win the race to bring in the next blockbuster drug to market and milestones of innovative therapeutics. It encourages the mutual understanding between basic research and commercial purposes. It will be a unique conference place for updating both knowledge and translating cutting-edge scientific outcome and technology into industrial productivity for a new healthier world. Through IDDST congress 2009, you will gain a full coverage on the up-to-date with the booming drug R&D industry and its partnering potential in Asia, also deeply understand the market and current situation to get what you need, such as the strategies of major pharma players in integrating scientific, technological, talent and business resources in a flat world to increase business competitive capacities.
The congress of IDDST, initiated by BIT Life Sciences in 2003, has offered a unique across cultural meeting place of drug discovery in China. In the past six years, the congresses of IDDST have attracted more than world renowned speakers with over 40,000 professionals around the world as a leading international event for the professionals to sharing scientific information and seeking business opportunities in drug discovery fields through the annual congress and our tech tour programs in different cities of China. Many world prominent scientists, senior executives, entrepreneurs, and investors have joined us enthusiastically with diversified contributions to each congress of IDDST. You may find the Collection of previous conferences as following.
IDDST Congress 2009 is your best chance to showcase to drug discovery professionals in China.Developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee break, and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits. The IDDST 2009 will take place at Shanghai Everbright Convention and Exhibition Center. Lectures will be held on the 2nd floor of the build, immediately close to the exhibition area.
Why should you sponsor this event? IDDST Congress 2009 is where your clients will come to look for solutions you can provide.
The event will offer a variety of conference and networking formats including; workshops, plenary sessions, parallel sessions, speed networking and a sociable drinks reception.
As a sponsor of this event you will be able to consider the most appropriate way to present your products and services and select a sponsorship package that is best suited to your marketing objectives and your preferred communication style. This event will deliver an excellent marketing and networking opportunity. By sponsoring or exhibiting at this event you will:
Learn from top level speakers
Uncover new opportunities and generate leads
Gain access to your target market
Integrate with the outsourcing and operations community
About IDDST
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.JPG)
.jpg)
Thank Merck for the generous sponsorship to IDDST-2009
